Drug intelligence / Profile preview

Abter

Development stage
Unknown
Lead developer
Zytras Life Sciences
Modality
Small Molecules
Administration
Intramuscular
01

Overview

Abter is an antimalarial pharmaceutical formulation containing Alpha-Beta Arteether, a semi-synthetic derivative of artemisinin. It is specifically produced as a 150mg/2ml injectable solution intended for the treatment of malaria caused by Plasmodium parasites. The medication works by generating reactive free radicals within the parasite, leading to its destruction. Abter is manufactured and distributed by Zytras Life Sciences, an Indian PCD (Propaganda Cum Distribution) pharma franchise company. It is indicated for the treatment of uncomplicated malaria and is not recommended for malaria prophylaxis or for severe cases involving organ complications such as cerebral malaria. The drug must be administered by a healthcare professional via injection.

Brand names
Abter
Other names
Alpha-Beta Arteether injectionABTER 150ABTER150ABTER-150

Beyond the preview

Go deeper on Abter.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Abter.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call